Short-term longitudinal clinical, biochemical, and quality of life outcomes of medical or surgical therapy in unilateral primary aldosteronism
The findings showed that ADX generally provides superior clinical, biochemical, and QOL outcomes compared to MRAs in patients with uPA.
Authors
- Naoki Matsuda (ORCID: https://orcid.org/0000-0002-9363-1148)
- Yoshiro Matsuo (ORCID: https://orcid.org/0000-0003-0498-0846)
- Yuichi Yoshida (ORCID: https://orcid.org/0000-0001-8855-4099)
- Shotaro Miyamoto (ORCID: https://orcid.org/0000-0002-2538-9839)
- Takayuki Masaki (ORCID: https://orcid.org/0000-0002-2378-849X)
- Yumi Mori
- Koro Gotoh (ORCID: https://orcid.org/0000-0003-3190-1146)
- Nao Imaishi
- Yoshinori Ozeki (ORCID: https://orcid.org/0000-0002-0387-565X)
- Machiko Morita (ORCID: https://orcid.org/0009-0004-6638-1472)
- T. Noguchi (ORCID: https://orcid.org/0000-0001-7211-2595)
- Hirotaka Shibata (ORCID: https://orcid.org/0000-0001-6506-4820)
- Kentaro Sada (ORCID: https://orcid.org/0000-0002-0448-7165)
- Satoshi Nagai (ORCID: https://orcid.org/0009-0002-1440-4316)
- Chiaki Yonezu
Institutions
- Oita University (JP)
- Oita University of Nursing and Health Sciences (JP)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3389/fendo.2025.1558837
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health, Labour and Welfare